Acknowledgement
Supported by : (주)한독
References
- Akazawa N, Choi Y, Miyaki A, Tanabe Y, Sugawara J, Ajisaka R, Maeda S. 2012. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutr. Res. 32:795-799. https://doi.org/10.1016/j.nutres.2012.09.002
- Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. 2007. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4:807-818. https://doi.org/10.1021/mp700113r
- Artursson P, Karlsson J. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175:880-885. https://doi.org/10.1016/0006-291X(91)91647-U
- Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Goggins WB, Zee BC, Cheng KF, Fong CY, Wong A, Mok H, Chow MS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CY, Chan MH, Szeto S, Chan IH, Mok V. 2008. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 28:110-113. https://doi.org/10.1097/jcp.0b013e318160862c
- Beevers CS, Zhou H, Huang S. 2013. Hitting the golden TORget: curcumin's effects on mTOR signaling. Anti-cancer Agent Me. 13:988-994. https://doi.org/10.2174/1871520611313070004
- Chandran B, Goel A. 2012. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res. 26:1719-1725. https://doi.org/10.1002/ptr.4639
- Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. 2012. Curcumin extract for prevention of type 2 diabetes. Diabetes Care 35:2121-2127. https://doi.org/10.2337/dc12-0116
- Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ. 2005.Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidem. Biomar. Prev. 14: 120-125.
- Golombick T, Diamond TH, Manoharan A, Ramakrishna R. 2012. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, doubleblind placebo-controlled cross-over 4g study and an open-label 8g extension study. Am. J. Hematol. 87:455-460. https://doi.org/10.1002/ajh.23159
- Gupta NK, Dixit VK. 2011. Bioavailability enhancement of curcumin by complexation with phosphatidyl choline. J. Pharm.Sci. 100:1987-1995. https://doi.org/10.1002/jps.22393
- Holder GM, Plummer JL, Ryan AJ. 1978. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica. 8:761-768. https://doi.org/10.3109/00498257809069589
- Ide H, Tokiwa S, Sakamaki K, Nishio K, Isotani S, Muto S, Hama T, Masuda H, Horie S. 2010. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostatespecific antigen. Prostate. 70:1127-1133 https://doi.org/10.1002/pros.21147
- Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. 2005. Cancer statistics, 2005. CA Cancer J. Clin. 55:10-30. https://doi.org/10.3322/canjclin.55.1.10
- Kurita T, Makino Y. 2013. Novel curcumin oral delivery systems. Anticancer Res. 33:2807-2821.
- Li C, Zhang Y, Su T, Feng L, Long Y, Chen Z. 2012. Silicacoated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin. Int. J. Nanomedi. 7:5995-6002.
- Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffrey A, Mahanian M, Liu PT, Hewison M, Mizwickie M, Cashman J, Fiala M. 2009. 1 alpha, 25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J. Alzheimers Dis. 17:703-717. https://doi.org/10.3233/JAD-2009-1080
- Meibohm B, Beierle I, Derendorf H. 2002. How important are gender differences in pharmacokinetics? Clin. Pharmacokinet. 41:329-342. https://doi.org/10.2165/00003088-200241050-00002
- Morimoto T, Sunagawa Y, Katanasaka Y, Hirano S, Namiki M, Watanabe Y, Suzuki H, Doi O, Suzuki K, Yamauchi M, Yokoji T, Miyoshi-Morimoto E, Otsuka Y, Hamada T, Imaizumi A, Nonaka Y, Fuwa T, Teramoto T, Kakeya H, Wada H, Hasegawa K. 2013. Drinkable preparation of Theracurmin exhibits high absorption efficiency-a single-dose, double-blind, 4-way crossover study. Biol. Pharm. Bull. 36:1708-1714. https://doi.org/10.1248/bpb.b13-00150
- Na LX, Yan BL, Jiang S, Cui HL, Li Y, Sun CH. 2014. Curcuminoids target decresing serum adipocyte-fatty acid binding protein levels in their glucose-lowering effect in patients with type 2 diabetes. Biomed. Environ. Sci. 27:902-906.
- Nakagawa Y, Mukai S, Yamada S, Matsuoka M, Tarumi E, Hashimoto T, Tamura C, Imaizumi A, Nishihira J, Nakamura T. 2014. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebocontrolled prospective study. J. Orthop. Sci. 19:933-939. https://doi.org/10.1007/s00776-014-0633-0
- Nazari QA, Kume T, Izuo N, Takada-Takatori Y, Imaizumi A, Hashimoto T, Izumi Y, Akaike A. 2013. Neuroprotective effects of curcumin and highly bioavailable curcumin on oxidative stress induced by sodium nitroprusside in rat striatal cell culture. Biol. Pharm. Bull. 36:1356-1362. https://doi.org/10.1248/bpb.b13-00300
- Nazari-Vanani R, Moezi L, Heli H. 2017. In vivo evaluation of a self-nanoemulsifying drug delivery system for curcumin. Biomed. Pharmacother. 88:715-720. https://doi.org/10.1016/j.biopha.2017.01.102
- Pawar YB, Purohit H, Valicherla GR, Munjal B, Lale SV, Patel SB, Bansal AK. 2012. Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach. Int. J. Pharm. 436:617-623. https://doi.org/10.1016/j.ijpharm.2012.07.031
- Ravindranath V, Chandrasekhara N. 1980. Absorption and tissue distribution of curcumin in rats. Toxicology 16:259-265. https://doi.org/10.1016/0300-483X(80)90122-5
-
Ravindranath V, Chandrasekhara N. 1981-1982. Metabolism of curcumin--studies with (
$^3H$ ) curcumin. Toxicology 22:337-344. - Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T. 2011. Innovative preparation of curcumin for improved oral bioavailability. Biol. Pharm. Bull. 34:660-665. https://doi.org/10.1248/bpb.34.660
- Schiborr C, Kocher A, Behnam D, Jandasek J, Toelstede S, Frank J. 2014. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol. Nutr. Food Res. 58: 516-527. https://doi.org/10.1002/mnfr.201300724
- Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN. 2009. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 37:223-230. https://doi.org/10.1016/j.ejps.2009.02.019
- Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP. 2001. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 7:1894-1900.
- Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. 1998. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64:353-356. https://doi.org/10.1055/s-2006-957450
- Soetikno V, Suzuki K, Veeraveedu PT, Arumugam S, Lakshmanan AP, Sone H, Watanabe K. 2013. Molecular understanding of curcumin in diabetic nephropathy. Drug Discov. Today 18:756-763. https://doi.org/10.1016/j.drudis.2013.04.009
- Sukardi R, Sastroasmoro S, Siregar NC, Djer MM, Suyatna FD, Sadikin M, Ibrahim N, Rahayuningsih SE, Witarto AB. 2016. The role of curcumin as an inhibitor of oxidative stress caused by ischaemia re-perfusion injury in tetralogy of Fallot patients undergoing corrective surgery. Cardiol. Young. 26:431-418. https://doi.org/10.1017/S1047951115000360
- Sunagawa Y, Hirano S, Katanasaka Y, Miyazaki Y, Funamoto M, Okamura N, Hojo Y, Suzuki H, Doi O, Yokoji T, Morimoto E, Takashi T, Ozawa H, Imaizumi A, Ueno M, Kakeya H, Shimatsu A, Wada H, Hasegawa K, Morimoto T. 2015. Colloidal submicron-particle curcumin exhibits high absorption efficiencya double-blind, 3-way crossover study. J. Nutr. Sci. Vitaminol (Tokyo). 61:37-44. https://doi.org/10.3177/jnsv.61.37
- Takahashi M, Uechi S, Takara K, Asikin Y, Wada K. 2009. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J. Agric. Food Chem. 57:9141-9146. https://doi.org/10.1021/jf9013923
- Tanabe Y, Maeda S, Akazawa N, Zempo-Miyaki A, Choi Y, Ra SG, Imaizumi A, Otsuka Y, Nosaka K. 2015. Attenuation of indirect markers of eccentric exercise-induced muscle damage by curcumin. Eur. J. Appl. Physiol. 115:1949-1957. https://doi.org/10.1007/s00421-015-3170-4
- Wan S, Sun Y, Qi X, Tan F. 2012. Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion. AAPS PharmSciTech. 13:159-166. https://doi.org/10.1208/s12249-011-9732-9
- Yan YD, Kim JA, Kwak MK, Yoo BK, Yong CS, Choi HG. 2011. Enhanced oral bioavailability of curcumin via a solid lipid-based self-emulsifying drug delivery system using a spraydrying technique. Biol. Pharm. Bull. 34:1179-1186. https://doi.org/10.1248/bpb.34.1179
- Yang H, Xu W, Zhou Z, Liu J, Li X, Chen L, Weng J, Yu Z. 2015. Curcumin attenuates urinary excretion of albumin in type II diabetic patients with enhancing nuclear factor erythroidderived 2-like 2 (Nrf2) system and repressing inflammatory signaling efficacies. Exp. Clin. Endocrinol. Diabetes. 123:360-367. https://doi.org/10.1055/s-0035-1545345